Co-Authors
This is a "connection" page, showing publications co-authored by Flora Peyvandi and Michael Makris.
Connection Strength
0.118
-
Adoption of emicizumab (Hemlibra®) for hemophilia A in Europe: Data from the 2020 European Association for Haemophilia and Allied Disorders survey. Haemophilia. 2021 Sep; 27(5):736-743.
Score: 0.060
-
Vaccination against COVID-19: Rationale, modalities and precautions for patients with haemophilia and other inherited bleeding disorders. Haemophilia. 2021 Jul; 27(4):515-518.
Score: 0.058